Therefore, while this antagonist has proved effective in controlling tumor progression in various cancers, these observations suggest caution in its use to understand the respective roles of CXCR4 and CXCR7 as mediators of the biological effects of CXCL12. This evidence concerns the gene CXCR4 and cancer.